Should Investors Sell Before SpaceX IPO Upends QQQ
SpaceX’s planned IPO could force immediate inclusion in Nasdaq-100 ETFs, igniting volatility for QQQ and other tracke...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesSpaceX’s planned IPO could force immediate inclusion in Nasdaq-100 ETFs, igniting volatility for QQQ and other tracke...
Alphabet and Amazon just posted strong Q1 results as AI infrastructure spending accelerates. This article weighs whic...
Solana is testing the Alpenglow upgrade with validator trials and a potential Q3 mainnet. Analysts weigh timing, risk...
When a chief operating officer sells stock, investors take notice. This article breaks down the implications, explain...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
In a move with broad market implications, Japan's finance ministry asks a major pension fund to tilt more toward dome...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Three AI infrastructure names join the S&P 500 in a quarterly rebalance, signaling AI hardware is moving from specula...
JPMorgan’s Dividend Leaders ETF shows a surprising income mismatch, posting a 1.59% yield while Treasuries offer more...
A $2 million nest egg can still be eaten away by a decade of pre-Medicare health costs. This story explains the hidde...
If your Social Security benefit is smaller than you hoped, you’re not out of luck. This guide explains how to verify ...